Authorized Disclosures. Subject to this Section 8.3, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 15 contracts
Samples: Licensing and Collaboration Agreement (Zymeworks Inc.), Collaboration and License Agreement (AbCellera Biologics Inc.), Collaboration and Cross License Agreement (Zymeworks Inc.)
Authorized Disclosures. Subject to this Section 8.3Notwithstanding the obligations set forth in Sections 11.1 and 11.5, the recipient a Party may disclose the other Party’s Confidential Information belonging (including this Agreement and the terms herein) to the other Party to the extent permitted as followsextent:
Appears in 13 contracts
Samples: , Development and Commercialization Agreement (Revolution Medicines, Inc.), Collaboration and License Agreement (Sangamo Therapeutics, Inc), License and Collaboration Agreement (Cytokinetics Inc)
Authorized Disclosures. Subject to this Section 8.310.3, the recipient Receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 5 contracts
Samples: License and Collaboration Agreement (Jazz Pharmaceuticals PLC), License and Collaboration Agreement (Zymeworks Inc.), Exclusive Option and License Agreement (Leap Therapeutics, Inc.)
Authorized Disclosures. Subject to this Section 8.3Notwithstanding the obligations set forth in Sections 7.1 and 7.5, the recipient a Party may disclose the other Party’s Confidential Information belonging to the other Party to the extent permitted as followsextent:
Appears in 3 contracts
Samples: License Agreement (Mereo Biopharma Group PLC), License Agreement (Chinook Therapeutics, Inc.), Collaboration and License Agreement (Immunome Inc.)
Authorized Disclosures. Subject to this Section 8.37.3, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 3 contracts
Samples: And License Agreement (Zymeworks Inc.), And License Agreement (Zymeworks Inc.), License Agreement (Zymeworks Inc.)
Authorized Disclosures. Subject to this Section 8.39.4, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 2 contracts
Samples: Research and License Agreement (Zymeworks Inc.), Research and License Agreement (Zymeworks Inc.)
Authorized Disclosures. Subject to this Section 8.39.3, the recipient Receiving Party may disclose the Disclosing Party’s Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 2 contracts
Samples: License Agreement (Erasca, Inc.), License Agreement (Erasca, Inc.)
Authorized Disclosures. Subject to this Section 8.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as followsParty:
Appears in 2 contracts
Samples: Patent Cross License Agreement (Alnylam Pharmaceuticals, Inc.), Patent Cross License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.311.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.39.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as followsParty:
Appears in 1 contract
Samples: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.311(c), the recipient receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: License Agreement (Biolargo, Inc.)
Authorized Disclosures. Subject to this Section 8.315(c), the recipient receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: License Agreement (Biolargo, Inc.)
Authorized Disclosures. Subject to this Section 8.311.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as followsParty:
Appears in 1 contract
Samples: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.39.3, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: Research Collaboration and License Agreement (BCTG Acquisition Corp.)
Authorized Disclosures. Subject to this Section 8.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party Party: Certain information in this Exhibit marked as [***] has been excluded pursuant to the extent permitted as follows:Regulation S-K, Item 601(b)(10). Such excluded information is not material and would be competitively harmful if publicly disclosed.
Appears in 1 contract
Samples: Collaboration and License Agreement (Centrexion Therapeutics Corp)
Authorized Disclosures. Subject to this Section 8.310.3 and Section 7 of Exhibit 2.8, the recipient Receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: Collaboration Agreement (Assembly Biosciences, Inc.)
Authorized Disclosures. Subject to this Section 8.37.3, the recipient Receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
